Company Filing History:
1 out of 155 
1 out of 23 
1 out of 4 Years Active: 2017
Title: The Innovative Contributions of Thomas Giese
Introduction
Thomas Giese is a notable inventor based in Schriesheim, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on improving the effectiveness of chemovirotherapy and radiovirotherapy for cancer patients.
Latest Patents
Thomas Giese holds a patent for "Methods of treating cancer using chemovirotherapy." This patent describes a diagnostic method for predicting a patient's response to chemovirotherapy or radiovirotherapy. The method involves exposing primary tumor cells from a patient, such as those obtained from brain tumors or pancreatic cancer, to a parvovirus and/or a chemotherapeutic agent or radiotherapy. The effectiveness of the treatment is determined by measuring the reduction of the expression or concentration of ISG15. He has 1 patent in total.
Career Highlights
Throughout his career, Thomas Giese has worked with prestigious institutions, including the German Cancer Research Center (Deutsches Krebsforschungszentrum) and Ruprecht-Karls-University Heidelberg. His research has contributed to advancements in cancer treatment methodologies, showcasing his dedication to improving patient outcomes.
Collaborations
Thomas Giese has collaborated with several professionals in his field, including Nathalia Giese and Jens Werner. These collaborations have further enriched his research and development efforts in cancer therapies.
Conclusion
Thomas Giese's innovative work in cancer treatment through chemovirotherapy and radiovirotherapy highlights his commitment to advancing medical science. His contributions are paving the way for more effective cancer treatments, ultimately benefiting patients worldwide.